McMaster Innovation Park and IMPACT at UCalgary Announce MOU to Enhance Access to Clinical Trials for Life Sciences Ventures

For Life Sciences venture companies, health-related innovations ready for clinical trials are being accelerated, through a Memorandum of Understanding between McMaster Innovation Park (MIP) and the Integrated Management Platform to Accelerate Clinical Trials (IMPACT) at the University of Calgary (UCalgary).

The MOU facilitates access to the leading-edge IMPACT clinical trial program for MIP tenant life sciences ventures, while providing opportunities for growing UCalgary IMPACT ventures to advance toward commercialization and manufacturing at MIP.